rs61752480

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_000036.3(AMPD1):​c.99A>G​(p.Gly33Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00452 in 1,614,210 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 34 hom. )

Consequence

AMPD1
NM_000036.3 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.271

Publications

3 publications found
Variant links:
Genes affected
AMPD1 (HGNC:468): (adenosine monophosphate deaminase 1) Adenosine monophosphate deaminase 1 catalyzes the deamination of AMP to IMP in skeletal muscle and plays an important role in the purine nucleotide cycle. Two other genes have been identified, AMPD2 and AMPD3, for the liver- and erythocyte-specific isoforms, respectively. Deficiency of the muscle-specific enzyme is apparently a common cause of exercise-induced myopathy and probably the most common cause of metabolic myopathy in the human. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
AMPD1 Gene-Disease associations (from GenCC):
  • myopathy due to myoadenylate deaminase deficiency
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • adenosine monophosphate deaminase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000036.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 1-114688677-T-C is Benign according to our data. Variant chr1-114688677-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 92333.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.271 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000036.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AMPD1
NM_000036.3
MANE Select
c.99A>Gp.Gly33Gly
synonymous
Exon 3 of 16NP_000027.3P23109-1
AMPD1
NM_001172626.2
c.87A>Gp.Gly29Gly
synonymous
Exon 2 of 15NP_001166097.2P23109-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AMPD1
ENST00000520113.7
TSL:1 MANE Select
c.99A>Gp.Gly33Gly
synonymous
Exon 3 of 16ENSP00000430075.3P23109-1
AMPD1
ENST00000369538.4
TSL:2
c.87A>Gp.Gly29Gly
synonymous
Exon 2 of 15ENSP00000358551.4P23109-2
AMPD1
ENST00000637080.1
TSL:5
n.102A>G
non_coding_transcript_exon
Exon 2 of 14ENSP00000489753.1A0A1B0GTL6

Frequencies

GnomAD3 genomes
AF:
0.00305
AC:
464
AN:
152214
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000820
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00311
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00456
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00269
AC:
676
AN:
251472
AF XY:
0.00267
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.00185
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00379
Gnomad NFE exome
AF:
0.00396
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00467
AC:
6831
AN:
1461878
Hom.:
34
Cov.:
32
AF XY:
0.00451
AC XY:
3282
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.000747
AC:
25
AN:
33480
American (AMR)
AF:
0.00174
AC:
78
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000574
AC:
15
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00111
AC:
96
AN:
86252
European-Finnish (FIN)
AF:
0.00391
AC:
209
AN:
53420
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00549
AC:
6107
AN:
1112002
Other (OTH)
AF:
0.00493
AC:
298
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
393
786
1180
1573
1966
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00305
AC:
464
AN:
152332
Hom.:
3
Cov.:
32
AF XY:
0.00305
AC XY:
227
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000818
AC:
34
AN:
41580
American (AMR)
AF:
0.00471
AC:
72
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4820
European-Finnish (FIN)
AF:
0.00311
AC:
33
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00456
AC:
310
AN:
68034
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00393
Hom.:
0
Bravo
AF:
0.00267
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00491
EpiControl
AF:
0.00344

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Muscle AMP deaminase deficiency (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
6.7
DANN
Benign
0.57
PhyloP100
-0.27
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs61752480;
hg19: chr1-115231298;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.